Alport Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Video
• Funding
• Clinical Trials

European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
Conditions:   Alport Syndrome;   Hereditary Kidney Disease;   Pediatric Kidney Disease;   Thin Basement Membrane Disease;   Familial Benign HematuriaInterventions:   Drug: ACE-inhibitor;   Drug: AT1-inhibitor;   Drug: HMG-Coenzyme inhibitor (statin);   Drug: Spironolactone;   Drug: ParicalcitolSponsors:   University Hospital Goettingen;   Gesellschaft für Pädiatrische Nephrologie;   Deutsche Gesellschaft für Nephrologie;   Alport Selbsthilfe e.V.;   Association pour l'Information et la Recherche sur les Maladies Rénales Génétiques (AIRG);   KfH Foundation Preventive Me...
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials

ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition:   Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention:   Sponsor:   Regulus Therapeutics Inc.Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2014 Category: Research Source Type: clinical trials